Authors


Lauren Forni, PharmD, MBA

Latest:

Hospitals Can Leverage Data From Second-Generation Technology for More Effective Drug Diversion Prevention

AI and other technologies, in conjunction with ASHP’s guidelines, can improve drug diversion monitoring and outcomes.


Gracie J. Shidler

Latest:

Changes in the Law Result From OTC Drug Product Tampering

Chicago Tylenol murders still reverberates after 40 years; they changed medication packaging forever.


Yassmeen Marzuq, PharmD

Latest:

Impact of Pharmacist-Led Initiatives on Health Care–Associated Clostridioides difficile Rates

Antimicrobial stewardship efforts focusing on accurate penicillin allergy histories, β-lactam cross-reactivity education, and guideline-driven narrow-spectrum prescribing may help sustainably decrease health care–associated Clostridioides difficile infection rates.


Kevin Nguyen, PharmD

Latest:

Shorter Course of Treatment for CAP in Children Demonstrates Success

Pediatric guidelines suggest 10 days of therapy for community-acquired pneumonia, but recent data support shortening therapy duration.


Ethan A. Smith, PharmD, BCIDP

Latest:

Precision in Practice: Optimizing Probability of Beta-Lactam Target Attainment with Prolonged Infusions and Therapeutic Drug Monitoring

As data continue to develop in this arena, β-lactam therapeutic drug monitoring is likely to become more routine, as it has with drugs like vancomycin and the aminoglycosides.



Yasmeen Ettrick, PharmD Candidate

Latest:

Multilingual Medicine: A Pharmacist’s Impact on Inclusive Health Care

Patricia Gutierrez, PharmD, BCACP, CDE, aims to combat the challenges in culturally competent care with knowledge and love for her community and patients.


Rachel Anne Friend, PharmD Candidate

Latest:

Migraine Awareness Month: A Pharmacist’s Role in Dynamic Management

The increased negative health outcomes associated with migraines provide an opportunity for pharmacists in both the inpatient and outpatient setting to support patients.


Zyanya Rizzo, PharmD Candidate

Latest:

Assessing Philadelphia-Like B-Cell ALL in a Largely Hispanic Population

Ph-like ALL may be predominantly prevalent in Hispanic and Latino populations.


Raja M. Din, MD

Latest:

How Integrating Research Into Private Pharmacy Practice Can Support Care and Diversity in Clinical Trials

By taking a research-based approach, clinical trials can become more diverse and better serve the needs of all individuals.


Ellen Berkley, PharmD

Latest:

Artificial Intelligence Applications in Education and Pharmacy Practice

By interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.


Don Lazas, MD

Latest:

How Integrating Clinical Trials Into Private Practice Can Benefit Both Patients, Physicians

Having scheduled check-ins for an ongoing trial arguably helps patients feel more informed and in charge of their health.


Hawon Jung

Latest:

Pain Management in the ICU Is Complex

Finding the right medication or drug combination for individual patients is critical.



Anna Hall

Latest:

Future-Proofing Pharmacies Amid a Changing Health Care Landscape

New tools and technology applications proliferate as multiple, industrywide shifts take hold in pharmacy.



American Institute of the History of Pharmacy

Latest:

‘First Day Cover’ Collection Marks 50th Anniversary of Pharmacy Stamp

American Institute of the History of Pharmacy posts the collection of pharmacist Daniel Shifrin on its website.


Jamila Beckford, PharmD Candidate

Latest:

Bridging the Gap: How Pharmacists Can Expand and Transform Mental Health Services

This expansion of their role goes beyond traditional dispensing duties, positioning pharmacists as an essential bridge between patients and the broader health care system.


Brooke Kempf, PMHNP

Latest:

Improving Schizophrenia Outcomes: The Role of Long-Acting Injectables and Medication Adherence

Offering pharmacy professionals insights into the benefits, importance and challenges associated with switching patients to long-acting injectables to treat schizophrenia.



Alexandra Gerlach, Associate Editor

Latest:

Pulmonary Hypertension Associated With Increased Risk of Progression in Patients With Myeloproliferative Neoplasms

Pulmonary hypertension significantly increases the risk of disease progression and cardiovascular events in patients with myelofibrosis, emphasizing a need for routine screening.


Kristin Busse, PharmD, BCPS

Latest:

Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology Patients

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.


Ashley Gallagher, Editor

Latest:

John Green: "Tuberculosis Anywhere Is a Threat to People Everywhere"

Tuberculosis is a long-standing global health issue that requires continued public health vigilance to prevent a resurgence of this preventable and curable disease.



Marisol Ramirez, CPhT

Latest:

Pharmacy-Led Enhanced Patient Education in the Emergency Department

In this retrospective study, investigators evaluated a pharmacy-led initiative in the emergency department (ED), finding a potential reduction in ED revisits and hospital readmissions, though results were not statistically significant.


Elizabeth DeMarco, PharmD, BCPS

Latest:

Streamlining Pain Management: Shore Medical Center's Pharmacist-Driven Opioid Conversion Initiative

Shore Medical Center enhances patient safety with a pharmacy-driven intravenous to oral opioid conversion protocol, minimizing risks and improving pain management.


Alexandra Burger, PharmD

Latest:

TXNIP inhibitors: A New Class of Agents for Diabetes Treatment

TXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.


Hosep Ohanian, PharmD candidate

Latest:

A Review of Treatment Options, Guidelines for Heart Failure With Preserved Ejection Fraction

With the release of the 2022 AHA/ACC Guidelines for the Management of Heart Failure, patients with HFpEF now have a wider range of treatment options.


Sabree Burbage, PharmD, MPH

Latest:

PQA-Supported Research Examines Cost Barriers to Medication Access and Adherence

The Pharmacy Quality Alliance developed the “Medication Access Framework for Quality Measurement” to address the social determinants of health that hinder patient medication access and contribute to poor health outcomes.


Liz Oler, PharmD

Latest:

Pharmacy’s Role in Public Health Initiatives

Panelists share final thoughts and advice regarding the critical role pharmacy has played and continues to play in public health initiatives.